The central nervous system (CNS) stimulant drugs market is witnessing steady growth, driven by the rising prevalence of neurological and psychiatric disorders. According to recent data, the market reached a valuation of USD 10.98 Billion in 2024 and is projected to expand at a CAGR of 7.30% during 2025–2034. By the end of the forecast period, the market is expected to hit around USD 2... https://www.expertmarketresearch.com/reports/central-nervous-system-stimulant-drugs-market